ATLANTA, GEORGIA (September 17, 2018) – The American Lung Association will hold three educational sessions for health professionals on the latest statistics, treatment options, and chronic obstructive pulmonary disease (COPD) research findings this fall in Atlanta, Georgia (September 27, 2018), Long Beach, California (October 18, 2018), and Dallas/Ft. Worth, Texas (November 15, 2018). These CME-certified sessions, Gold 2018 Highlights: A New Approach to COPD Management, are held in areas recently named as having among the highest COPD prevalence by the Centers for Disease Control and Prevention (CDC), primarily due to smoking rates and poor air quality.
All sessions are based on the recently published 2018 GOLD Report, which provides comprehensive recommendations for the diagnosis, assessment, and management of COPD. Important factors affecting clinician uptake of the recommendations include a lack of familiarity with or delayed adoption of GOLD 2018 therapeutic strategy, undertreatment or mistreatment based on disease severity, lack of individualization of management plans, and a lack of patient self-management support.
GOLD 2018 Highlights: A New Approach to COPD Management will review the new recommendations and enable clinicians to apply assessment and management strategies that incorporate the latest evidence to guide development of individualized management plans for patients with COPD. The activity is intended for pulmonologists, advanced practice nurses, respiratory therapists, and other healthcare professionals who treat COPD in the community setting.
The Potomac Center for Medical Education designates the activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. At its conclusion, participants should be able to demonstrate the ability to:
- Discuss the new recommendations of the GOLD 2018 therapeutic strategy and its impacts on the diagnosis, assessment, and treatment of COPD.
- Apply GOLD 2018 assessment and management strategies, incorporating the latest clinical evidence to guide development of individualized management plans.
This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals and was planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.
To register for Gold 2018 Highlights: A New Approach to COPD Management, health professionals should visit www.rockpointe.com/alacopd.
Through effective continuing medical education, Rockpointe strives to improve and advance the quality of patient care. Its educational programs have been at the forefront of new issues in healthcare, including developments in specialties such as pulmonology, combatting the nation’s opioid crisis, and utilizing technical advances that improve care. As part of its commitment to quality, Rockpointe works to inform the continuing-education community of significant quality-improvement issues through news and analysis on Policy and Medicine. In addition, its popular (MEDX) CME regional meetings include sessions on the basics of quality improvement and alternative payment models, as well as relevant and scientifically accurate sessions on numerous disease states. At Rockpointe, education equals quality.
About the American Lung Association
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease through research, education, and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit: Lung.org.